These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7745028

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B, Young J, Kujas M, Meduri G, Brailly S, Thomas JL, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone, and prolactin in late gestation: a new method for the analysis of copulsatility.
    Albers N, Bettendorf M, Herrmann H, Kaplan SL, Grumbach MM.
    Endocrinology; 1993 Feb; 132(2):701-9. PubMed ID: 8425489
    [Abstract] [Full Text] [Related]

  • 47. Effect of endogenous opioid blockade on the amplitude and frequency of pulsatile luteinizing hormone secretion in normal men.
    Ellingboe J, Veldhuis JD, Mendelson JH, Kuehnle JC, Mello NK.
    J Clin Endocrinol Metab; 1982 Apr; 54(4):854-7. PubMed ID: 7061693
    [Abstract] [Full Text] [Related]

  • 48. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA, Reame NE, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [Abstract] [Full Text] [Related]

  • 49. Treatment of hyperprolactinemic amenorrhea with pulsatile gonadotropin-releasing hormone therapy.
    Gindoff PR, Loucopoulos A, Jewelewicz R.
    Fertil Steril; 1986 Dec; 46(6):1156-8. PubMed ID: 3536607
    [Abstract] [Full Text] [Related]

  • 50. Ovulation induction with a single-blind treatment regimen comparing naltrexone, placebo and clomiphene citrate in women with secondary amenorrhea.
    Armeanu MC, Moss RJ, Schoemaker J.
    Acta Endocrinol (Copenh); 1992 May; 126(5):410-5. PubMed ID: 1621484
    [Abstract] [Full Text] [Related]

  • 51. Pregnancy following monofollicular ovulation induction with recombinant FSH, recombinant LH and timed coitus in an amenorrheic woman with long-standing hypogonadotrophic hypogonadism.
    El-Shawarby SA, Turner CF, Reddy N, Margara RA, Trew GH, Lavery SA.
    BJOG; 2004 Dec; 111(12):1481-4. PubMed ID: 15663144
    [No Abstract] [Full Text] [Related]

  • 52. Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women.
    Botticelli G, Bacchi Modena A, Bresciani D, Villa P, Aguzzoli L, Florio P, Nappi RE, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1992 Dec; 15(11):839-47. PubMed ID: 1291596
    [Abstract] [Full Text] [Related]

  • 53. Advancement of first ovulation by the opioid antagonist naltrexone.
    Meijs-Roelofs HM, Kramer P.
    Biol Reprod; 1989 Nov; 41(5):842-7. PubMed ID: 2624852
    [Abstract] [Full Text] [Related]

  • 54. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
    de Wit W, Schoute E, Schoemaker J.
    J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
    [Abstract] [Full Text] [Related]

  • 55. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
    Matera C, Freda PU, Ferin M, Wardlaw SL.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
    [Abstract] [Full Text] [Related]

  • 56. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B, Young J, Brailly S, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [Abstract] [Full Text] [Related]

  • 57. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [Abstract] [Full Text] [Related]

  • 58. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
    Wildt L, Leyendecker G.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1334-5. PubMed ID: 3571432
    [Abstract] [Full Text] [Related]

  • 59. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
    de Wit W, Schoute E, Schoemaker J.
    J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
    [Abstract] [Full Text] [Related]

  • 60. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
    Matera C, Freda PU, Ferin M, Wardlaw SL.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.